Literature DB >> 25714676

Skeletal muscle dysfunction is associated with derangements in mitochondrial bioenergetics (but not UCP3) in a rodent model of sepsis.

Parjam S Zolfaghari1, Jane E Carré2, Nadeene Parker3, Nancy A Curtin4, Michael R Duchen3, Mervyn Singer2.   

Abstract

Muscle dysfunction is a common feature of severe sepsis and multiorgan failure. Recent evidence implicates bioenergetic dysfunction and oxidative damage as important underlying pathophysiological mechanisms. Increased abundance of uncoupling protein-3 (UCP3) in sepsis suggests increased mitochondrial proton leak, which may reduce mitochondrial coupling efficiency but limit reactive oxygen species (ROS) production. Using a murine model, we examined metabolic, cardiovascular, and skeletal muscle contractile changes following induction of peritoneal sepsis in wild-type and Ucp3(-/-) mice. Mitochondrial membrane potential (Δψm) was measured using two-photon microscopy in living diaphragm, and contractile function was measured in diaphragm muscle strips. The kinetic relationship between membrane potential and oxygen consumption was determined using a modular kinetic approach in isolated mitochondria. Sepsis was associated with significant whole body metabolic suppression, hypothermia, and cardiovascular dysfunction. Maximal force generation was reduced and fatigue accelerated in ex vivo diaphragm muscle strips from septic mice. Δψm was lower in the isolated diaphragm from septic mice despite normal substrate oxidation kinetics and proton leak in skeletal muscle mitochondria. Even though wild-type mice exhibited an absolute 26 ± 6% higher UCP3 protein abundance at 24 h, no differences were seen in whole animal or diaphragm physiology, nor in survival rates, between wild-type and Ucp3(-/-) mice. In conclusion, this murine sepsis model shows a hypometabolic phenotype with evidence of significant cardiovascular and muscle dysfunction. This was associated with lower Δψm and alterations in mitochondrial ATP turnover and the phosphorylation pathway. However, UCP3 does not play an important functional role, despite its upregulation.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  metabolism; mitochondria; uncoupling protein 3

Mesh:

Substances:

Year:  2015        PMID: 25714676      PMCID: PMC4420898          DOI: 10.1152/ajpendo.00562.2014

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  65 in total

1.  Measurement of proton leak and electron leak in isolated mitochondria.

Authors:  Charles Affourtit; Casey L Quinlan; Martin D Brand
Journal:  Methods Mol Biol       Date:  2012

2.  Thermoregulatory responses to lipopolysaccharide in the mouse: dependence on the dose and ambient temperature.

Authors:  Alla Y Rudaya; Alexandre A Steiner; Jared R Robbins; Alexander S Dragic; Andrej A Romanovsky
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2005-08-04       Impact factor: 3.619

3.  Superoxide activates mitochondrial uncoupling proteins.

Authors:  Karim S Echtay; Damien Roussel; Julie St-Pierre; Mika B Jekabsons; Susana Cadenas; Jeff A Stuart; James A Harper; Stephen J Roebuck; Alastair Morrison; Susan Pickering; John C Clapham; Martin D Brand
Journal:  Nature       Date:  2002-01-03       Impact factor: 49.962

Review 4.  A history of UCP1.

Authors:  D G Nicholls
Journal:  Biochem Soc Trans       Date:  2001-11       Impact factor: 5.407

5.  Recruitment of mitochondrial uncoupling protein UCP2 after lipopolysaccharide induction.

Authors:  Michal Růzicka; Eva Skobisová; Andrea Dlasková; Jitka Santorová; Katarína Smolková; Tomás Spacek; Markéta Zácková; Martin Modrianský; Petr Jezek
Journal:  Int J Biochem Cell Biol       Date:  2005-04       Impact factor: 5.085

6.  Expression of uncoupling protein 3 is upregulated in skeletal muscle during sepsis.

Authors:  Xiaoyan Sun; Curtis Wray; Xintian Tian; Per-Olof Hasselgren; James Lu
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-04-29       Impact factor: 4.310

7.  Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure.

Authors:  David Brealey; Sekhar Karyampudi; Thomas S Jacques; Marco Novelli; Ray Stidwill; Val Taylor; Ryszard T Smolenski; Mervyn Singer
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2003-11-06       Impact factor: 3.619

Review 8.  Mitochondria in health and disease: perspectives on a new mitochondrial biology.

Authors:  Michael R Duchen
Journal:  Mol Aspects Med       Date:  2004-08

9.  Cutting edge: Essential role of hypoxia inducible factor-1alpha in development of lipopolysaccharide-induced sepsis.

Authors:  Carole Peyssonnaux; Pilar Cejudo-Martin; Andrew Doedens; Annelies S Zinkernagel; Randall S Johnson; Victor Nizet
Journal:  J Immunol       Date:  2007-06-15       Impact factor: 5.422

10.  Energization-dependent endogenous activation of proton conductance in skeletal muscle mitochondria.

Authors:  Nadeene Parker; Charles Affourtit; Antonio Vidal-Puig; Martin D Brand
Journal:  Biochem J       Date:  2008-05-15       Impact factor: 3.857

View more
  13 in total

1.  Hydrogen sulfide prevents diaphragm weakness in cecal ligation puncture-induced sepsis by preservation of mitochondrial function.

Authors:  Hai-Xia Zhang; Jun-Ming Du; Zhong-Nuo Ding; Xiao-Yan Zhu; Lai Jiang; Yu-Jian Liu
Journal:  Am J Transl Res       Date:  2017-07-15       Impact factor: 4.060

2.  MitoTEMPOL, a mitochondrial targeted antioxidant, prevents sepsis-induced diaphragm dysfunction.

Authors:  Gerald S Supinski; Lin Wang; Elizabeth A Schroder; Leigh Ann P Callahan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-05-27       Impact factor: 5.464

3.  AMP-Activated Protein Kinase and Glycogen Synthase Kinase 3β Modulate the Severity of Sepsis-Induced Lung Injury.

Authors:  Zhongyu Liu; Nathaniel Bone; Shaoning Jiang; Dae Won Park; Jean-Marc Tadie; Jessy Deshane; Cilina Ann Rodriguez; Jean-Francois Pittet; Edward Abraham; Jaroslaw W Zmijewski
Journal:  Mol Med       Date:  2015-11-30       Impact factor: 6.354

Review 4.  Skeletal Muscle and Lymphocyte Mitochondrial Dysfunctions in Septic Shock Trigger ICU-Acquired Weakness and Sepsis-Induced Immunoparalysis.

Authors:  Quentin Maestraggi; Benjamin Lebas; Raphaël Clere-Jehl; Pierre-Olivier Ludes; Thiên-Nga Chamaraux-Tran; Francis Schneider; Pierre Diemunsch; Bernard Geny; Julien Pottecher
Journal:  Biomed Res Int       Date:  2017-05-15       Impact factor: 3.411

5.  Impact of hyperglycemia on cystathionine-γ-lyase expression during resuscitated murine septic shock.

Authors:  Tamara Merz; Josef A Vogt; Ulrich Wachter; Enrico Calzia; Csaba Szabo; Rui Wang; Peter Radermacher; Oscar McCook
Journal:  Intensive Care Med Exp       Date:  2017-06-14

6.  Systemic bioinformatics analysis of skeletal muscle gene expression profiles of sepsis.

Authors:  Fang Yang; Yumei Wang
Journal:  Exp Ther Med       Date:  2018-04-03       Impact factor: 2.447

7.  Tumor protein 53-induced nuclear protein 1 deficiency alters mouse gastrocnemius muscle function and bioenergetics in vivo.

Authors:  Julie Warnez-Soulie; Michael Macia; Sophie Lac; Emilie Pecchi; Monique Bernard; David Bendahan; Marc Bartoli; Alice Carrier; Benoît Giannesini
Journal:  Physiol Rep       Date:  2019-05

Review 8.  Is REDD1 a Metabolic Éminence Grise?

Authors:  Christopher Lipina; Harinder S Hundal
Journal:  Trends Endocrinol Metab       Date:  2016-09-06       Impact factor: 12.015

9.  Chronic muscle weakness and mitochondrial dysfunction in the absence of sustained atrophy in a preclinical sepsis model.

Authors:  Allison M Owen; Samir P Patel; Jeffrey D Smith; Beverly K Balasuriya; Stephanie F Mori; Gregory S Hawk; Arnold J Stromberg; Naohide Kuriyama; Masao Kaneki; Alexander G Rabchevsky; Timothy A Butterfield; Karyn A Esser; Charlotte A Peterson; Marlene E Starr; Hiroshi Saito
Journal:  Elife       Date:  2019-12-03       Impact factor: 8.140

Review 10.  Sepsis therapies: learning from 30 years of failure of translational research to propose new leads.

Authors:  Jean-Marc Cavaillon; Mervyn Singer; Tomasz Skirecki
Journal:  EMBO Mol Med       Date:  2020-03-16       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.